(Q40714107)

23 September 2017

title

Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis (English)

1 reference

23 September 2017

Sang-Youel Park

1

1 reference

23 September 2017

Dai-Wu Seol

series ordinal

2

1 reference

23 September 2017

publication date

1 July 2002

1 reference

Biochemical and Biophysical Research Communications

23 September 2017

number of pages

4

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

23 September 2017

volume

295

1 reference

23 September 2017

issue

2

1 reference

23 September 2017

page(s)

515-518

1 reference

Growth factor receptor tyrosine kinases

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

The epidermal growth factor receptor in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Receptors for epidermal growth factor and other polypeptide mitogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Epidermal growth factor-related peptides and their receptors in human malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Signal transduction by receptors with tyrosine kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Apoptosis by death factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

2.8 A resolution crystal structure of human TRAIL, a cytokine with selective antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

A caspase-9 variant missing the catalytic site is an endogenous inhibitor of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Hypoxia inhibition of apoptosis induced by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Epidermal growth factor induces cyclin D1 in a human prostate cancer cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

The epidermal growth factor receptor and its inhibition in cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Bcl-XL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2802%2900719-2

10.1016/S0006-291X(02)00719-2

7 January 2021

Identifiers

DOI

1 reference

23 September 2017

1 reference